Protein arginine methylation: from enigmatic functions to therapeutic targeting

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Nature reviews. Drug discovery

• Publication date

  2021-03-19

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/s41573-021-00159-8PMID 33742187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PRMT5 inhibition disrupts splicing and stemness in glioblastoma

  2021cited by this paper
• Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.

  2021cited by this paper
• MAT2A inhibition blocks the growth of MTAP-deleted cancer cells by reducing PRMT5-dependent mRNA splicing and inducing DNA damage.

  2021cited by this paper
• Discovery of a First-in-class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor.

  2020cited by this paper
• Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5).

  2020cited by this paper
• Nna1 gene deficiency triggers Purkinje neuron death by tubulin hyperglutamylation and ER dysfunction

  2020cited by this paper
• A Chemical Probe for the Methyl Transferase PRMT5 with a Novel Binding Mode.

  2020cited by this paper
• Post-translational modifications of Hsp90 and translating the chaperone code

  2020cited by this paper
• Protein Arginine N-methyltransferases 5 and 7 Promote HIV-1 Production

  2020cited by this paper
• Methylation of HSP70 Orchestrates Its Binding to and Stabilization of BCL2 mRNA and Renders Pancreatic Cancer Cells Resistant to Therapeutics

  2020cited by this paper
• A First-in-class, Highly Selective and Cell-active Allosteric Inhibitor of Protein Arginine Methyltransferase 6 (PRMT6)

  2020cited by this paper
• Modulating the modulators: regulation of protein arginine methyltransferases by post-translational modifications.

  2020cited by this paper
• Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling.

  2020cited by this paper
• Arginine methylation of SHANK2 by PRMT7 promotes human breast cancer metastasis through activating endosomal FAK signalling

  2020cited by this paper
• Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response

  2020cited by this paper
• Inhibition of Protein arginine methyltransferase 6 reduces reactive oxygen species production and attenuates aminoglycoside- and cisplatin-induced hair cell death

  2020cited by this paper
• Discovery of First-in-class Protein Arginine Methyltransferase 5 (PRMT5) Degraders.

  2020cited by this paper
• Post-translational modifications of Hsp70 family proteins: Expanding the chaperone code

  2020cited by this paper
• PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.

  2020cited by this paper
• PRMT1 Is Recruited via DNA-PK to Chromatin Where It Sustains the Senescence-Associated Secretory Phenotype in Response to Cisplatin.

  2020cited by this paper
• PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis

  2019cited by this paper
• A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion

  2019cited by this paper
• Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.

  2019cited by this paper
• Targeting protein methylation: from chemical tools to precision medicines

  2019cited by this paper
• Foxp3 Post-translational Modifications and Treg Suppressive Activity

  2019cited by this paper
• Proteomics profiling of arginine methylation defines PRMT5 substrate specificity

  2019cited by this paper
• Abstract 4711: PRMT5 selective inhibitor enhances therapeutic efficacy of cisplatin in lung adenocarcinoma cells

  2019cited by this paper
• Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6

  2019cited by this paper
• Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice.

  2019cited by this paper
• Immune control by amino acid catabolism during tumorigenesis and therapy

  2019cited by this paper
• Abstract 950: In vivo efficacy and pharmacodynamic modulation of JNJ-64619178, a selective PRMT5 inhibitor, in human lung and hematologic preclinical models

  2019cited by this paper
• PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?

  2019cited by this paper
• A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy

  2019cited by this paper
• Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers

  2019cited by this paper
• Asymmetrical methyltransferase PRMT3 regulates human mesenchymal stem cell osteogenesis via miR-3648

  2019cited by this paper
• Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells.

  2019cited by this paper
• DNA Damage Repair in Huntington’s Disease and Other Neurodegenerative Diseases

  2019cited by this paper
• Liquid-Liquid Phase Separation in Disease.

  2019cited by this paper
• CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis.

  2019cited by this paper
• PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells

  2019cited by this paper
• Arginine methylation‐dependent LSD1 stability promotes invasion and metastasis of breast cancer

  2019cited by this paper
• Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade.

  2019cited by this paper
• The regulation, functions and clinical relevance of arginine methylation

  2019cited by this paper
• Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9

  2019cited by this paper
• PRMT5 is necessary to form distinct cartilage identities in the knee and long bone.

  2019cited by this paper
• PRMT5 inhibition modulates E2F1 methylation and gene regulatory networks leading to therapeutic efficacy in JAK2V617F mutant MPN.

  2019cited by this paper
• Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.

  2019cited by this paper
• Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors

  2019cited by this paper
• Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.

  2019cited by this paper
• The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma

  2019cited by this paper
• Methylation determines the extracellular calcium sensitivity of the leak channel NALCN in hippocampal dentate granule cells

  2019cited by this paper
• Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis

  2019cited by this paper
• Metadherin–PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT–β-catenin signaling pathway

  2019cited by this paper
• Chemical Probes for Protein Arginine Methyltransferases.

  2019cited by this paper
• PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia

  2019cited by this paper
• Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys

  2019cited by this paper
• Methyltransferase Inhibitors: Competing with, or Exploiting the Bound Cofactor

  2019cited by this paper
• Intracellular sensing of viral genomes and viral evasion

  2019cited by this paper
• The timeline of epigenetic drug discovery: from reality to dreams

  2019cited by this paper
• The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer

  2019cited by this paper
• The expanding landscape of ‘oncohistone’ mutations in human cancers

  2019cited by this paper
• PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185erbB2/neu Tumor Immunotherapy

  2019cited by this paper
• PRMT4 overexpression aggravates cardiac remodeling following myocardial infarction by promoting cardiomyocyte apoptosis.

  2019cited by this paper
• PRMT1 loss sensitizes cells to PRMT5 inhibition

  2019cited by this paper
• Cellular consequences of arginine methylation

  2019cited by this paper
• METEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

  2019cited by this paper
• Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma

  2019cited by this paper
• Protein Arginine Methyltransferases in Cardiovascular and Neuronal Function

  2019cited by this paper
• A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.

  2019cited by this paper
• Protein arginine methyltransferase 5 promotes bladder cancer growth through inhibiting NF-kB dependent apoptosis

  2018cited by this paper
• Loss of PRMT5 promotes PDGFRα degradation during oligodendrocyte differentiation and myelination

  2018cited by this paper
• CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity

  2018cited by this paper
• PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.

  2018cited by this paper
• MPTAC Determines APP Fragmentation via Sensing Sulfur Amino Acid Catabolism.

  2018cited by this paper
• LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.

  2018cited by this paper
• Mechanistic View of hnRNPA2 Low-Complexity Domain Structure, Interactions, and Phase Separation Altered by Mutation and Arginine Methylation.

  2018cited by this paper
• Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis

  2018cited by this paper
• Protein–RNA interactions: structural characteristics and hotspot amino acids

  2018cited by this paper
• A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy

  2018cited by this paper
• Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis

  2018cited by this paper
• PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma

  2018cited by this paper
• Inhibition of protein arginine methyltransferase 3 activity selectively impairs liver X receptor‐driven transcription of hepatic lipogenic genes in vivo

  2018cited by this paper
• Kinetic Analysis of PRMT1 Reveals Multifactorial Processivity and a Sequential Ordered Mechanism

  2018cited by this paper
• Arginine methyltransferase inhibitor-1 inhibits sarcoma viability in vitro and in vivo

  2018cited by this paper
• Protein arginine methylation: an emerging regulator of the cell cycle

  2018cited by this paper
• Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression

  2018cited by this paper
• PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.

  2018cited by this paper
• RGG/RG Motif Regions in RNA Binding and Phase Separation.

  2018cited by this paper
• PRMT1 Deficiency in Mouse Juvenile Heart Induces Dilated Cardiomyopathy and Reveals Cryptic Alternative Splicing Products

  2018cited by this paper
• Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.

  2018cited by this paper
• Stem cell fate in cancer growth, progression and therapy resistance

  2018cited by this paper
• CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer.

  2018cited by this paper
• PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer

  2018cited by this paper
• Cardiac specific PRMT1 ablation causes heart failure through CaMKII dysregulation

  2018cited by this paper
• Expanding the clinical and molecular spectrum of PRMT7 mutations: 3 additional patients and review

  2018cited by this paper
• PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice

  2018cited by this paper
• Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation.

  2018cited by this paper
• TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma

  2018cited by this paper
• PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes.

  2018cited by this paper
• Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.

  2018cited by this paper

• Engineering Tick Evasins as Multitarget Chemokine Inhibitors─A Biomimetic Approach To Tackling the Complexity of the Immune System.

  2026cites this paper
• Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment

  2026influential citation
• PRMT5 upregulates KCNMB4 expression via histone methylation to promote paclitaxel resistance in advanced nasopharyngeal carcinoma

  2026cites this paper
• Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway.

  2026cites this paper
• PRMT5 inhibits the ferroptosis of hepatocellular carcinoma via regulating RBM15/FTH1 signaling.

  2026cites this paper
• Arginine Methylation Antagonizes TEAD3-Mediated Repression to Promote Osteogenic Differentiation by Disrupting RUNX2-Sequestrating Condensates.

  2026cites this paper
• TDRD3, a Tudor domain-containing protein, regulates Klf2-dependent Treg differentiation and function to modulate immune tolerance

  2026cites this paper
• Fusion oncoproteins orchestrate tumorigenesis and sustain malignant progression via a positive feedback mechanism

  2026cites this paper
• Protein arginine methyltransferase 3: Mechanism of action in diseases and modulator discovery

  2026cites this paper
• LC-MS profiling of prmt-1 and prmt-5 knockout C. elegans reveals PRMT-1 substrates and global proteome remodeling

  2026cites this paper
• Prmt1-mediated methylation of Ddx17 promotes osteoblast differentiation via regulating the alternative splicing of Sh2b1.

  2026cites this paper
• Protein arginine methyltransferases in protozoan parasites: a new path for antiparasitic chemotherapy?

  2026cites this paper
• Separate transcription and splicing gene networks are linked and coordinated by the pRb–E2F pathway

  2026cites this paper
• Discovery of a potent and orally bioavailable type Ⅰ PRMTs inhibitor for triple-negative breast cancer treatment.

  2026cites this paper
• Decoding the metabolic-immune axis for novel therapeutics in bladder cancer.

  2026cites this paper
• Inhibition of Clostridioides difficile-specific DNA adenine methyltransferase CamA by analogs of S-adenosyl-l-methionine

  2025cites this paper
• Mina53 catalyzes arginine demethylation of p53 to promote tumor growth.

  2025cites this paper
• Substrate adaptors are flexible tethering modules that enhance substrate methylation by the arginine methyltransferase PRMT5

  2025cites this paper
• Protein arginine methyltransferase 7-mediated arginine mono-methylation stabilizes SRY-box transcription factor 9 to promote non-small cell lung cancer progression

  2025cites this paper
• Comparative analysis of plasma and bone marrow nutrient levels in pediatric B-ALL patients

  2025cites this paper
• Targeting ferroptosis as a novel strategy for depressive mental disorders.

  2025cites this paper
• Epigenetic control of antigen presentation failure in osteosarcoma: from single-cell chromatin maps to therapeutic strategies

  2025cites this paper
• Interplay of PRMTs and Identification of Biomarkers Through Machine Learning Algorithms in Pan‐Cancer, Highlighting PRMT3 as a Biomarker in Pancreatic Cancer

  2025influential citation
• Interferon‐Driven Biomarkers and Synergistic Therapy for PRMT5 Inhibition in Triple‐Negative Breast Cancer

  2025cites this paper
• Knockout of protein arginine methyltransferase 1 inhibited cell growth and promoted cell migration in human bronchial epithelial cells

  2025cites this paper
• PRMT1/PRMT5-Mediated Differential Arginine Methylation of CRIP1 Promotes the Recurrence of Small Cell Lung Cancer after Chemotherapy

  2025cites this paper
• Tumor-derived PRMT1 suppresses macrophage antitumor activity by inhibiting cGAS/STING signaling in gastric cancer cells

  2025cites this paper
• PRMT1‐mediated BRD4 arginine methylation and phosphorylation promote partial epithelial–mesenchymal transformation and renal fibrosis

  2025cites this paper
• Biomedical effects of protein arginine methyltransferase inhibitors

  2025cites this paper
• Epigenetic Regulation of Acute Lymphoblastic Leukemia

  2025cites this paper
• Enzymatic post-translational modifications of proteins in chronic kidney disease: mechanisms, regulation, and clinical significance

  2025cites this paper
• Arginine methylation regulates Ewing sarcoma cell viability in a EWSR1::FLI1 dependent manner and provides a therapeutic opportunity

  2025cites this paper
• A Collaborative Framework Integrating Large Language Model and Chemical Fragment Space: Mutual Inspiration for Lead Design

  2025cites this paper
• PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer

  2025cites this paper
• Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1

  2025cites this paper
• Methylation of RBM39 by PRMT6 enhances resistance to Indisulam in non-small cell lung cancer by promoting alternative splicing of proto-oncogenes

  2025cites this paper
• Functional Dynamics of Arginine Mono- and Di-Methylation

  2025cites this paper
• Expression landscape of epigenetic genes in human hepatocellular carcinoma

  2025cites this paper
• RIPK1 senses S-adenosylmethionine scarcity to drive cell death and inflammation.

  2025cites this paper
• Cardiac-specific overexpression of PRMT5 exacerbates pressure overload-induced hypertrophy and heart failure

  2025influential citation
• Phosphorylated Toll-like receptor 3 nuclear translocation in cancer cell promotes metastasis and chemoresistance

  2025cites this paper
• Congenital heart disease missense mutations in the TBX5 DNA-binding domain alter thermal stability and DNA-binding affinity

  2025cites this paper
• Protein arginine methyltransferase 5 as a novel therapeutic target in solid tumors

  2025cites this paper
• PRMT5: A Promising Synthetical Lethal Target for MTAP-Deleted Cancers.

  2025cites this paper
• Conductive Nanocomposite Hydrogels for Neural Tissue Engineering: A Systematic Scoping Review of Recent Trends

  2025cites this paper
• Multidrug resistance reversal effect of tenacissoside I through impeding EGFR methylation mediated by PRMT1 inhibition.

  2025cites this paper
• Tudor-based proteomic strategy pan-specifically enriches and identifies protein arginine methylation

  2025cites this paper
• L-citrulline protects testicular Sertoli cell function by mitigating DNA damage via the gut-testis axis of sheep fed a high-concentrate diet

  2025cites this paper
• Posttranslational modifications in Helicobacter pylori-associated gastric pathogenesis: Bridging inflammation and carcinogenesis.

  2025cites this paper
• Targeting PRMT5 in cancer: Mechanistic insights and clinical progress.

  2025cites this paper
• Arginine methylation patterns in LUAD: defining prognostic subtypes and relevance to immunotherapy

  2025cites this paper
• A step-by-step guide to performing cancer metabolism research using custom-made media

  2025cites this paper
• Protein Arginine Methyltransferases from Regulatory Function to Clinical Implication in Central Nervous System

  2025cites this paper
• PRMT1 promotes immune escape in hepatocellular carcinoma by regulating arginine methylation modification of MYC protein

  2025cites this paper
• Protein Arginine Methyltransferase 1-mediated Histone H4R3 Dimethyl Asymmetric enhances Epidermal Growth Factor Receptor signaling to promote Peritoneal Fibrosis

  2025cites this paper
• PRMT1‐Mediated SWI/SNF Complex Recruitment via SMARCC1 Drives IGF2BP2 Transcription to Enhance Carboplatin Resistance in Head and Neck Squamous Cell Carcinoma

  2025cites this paper
• Posttranslational Modification in Bone Homeostasis and Osteoporosis

  2025cites this paper
• Regulation of protein arginine methyltransferase in osteoporosis: a narrative review

  2025cites this paper
• Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy

  2025cites this paper
• Target Discovery Driven by Chemical Biology and Computational Biology

  2025cites this paper
• Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity

  2025cites this paper
• Design and Synthesis of Novel Deazapurine DNMT 1 Inhibitors with In Vivo Efficacy in DLBCL.

  2025cites this paper
• Implication of protein post translational modifications in gastric cancer

  2025cites this paper
• Targeting Protein Arginine Methyltransferases in Breast Cancer: Promising Strategies.

  2025cites this paper
• Arginine: at the crossroads of nitrogen metabolism

  2025cites this paper
• Opto-Epigenetic Regulation of Histone Arginine Asymmetric Dimethylation via Type I Protein Arginine Methyltransferase Inhibition

  2025cites this paper
• From DNA-Encoded Library Screening to AM-9747: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo Efficacy

  2025cites this paper
• OsPRMT5 methylates OsPAL1 to promote rice resistance, hindered by a Xanthomonas oryzae effector.

  2025cites this paper
• Identification of gene signatures and transcription factors associated with colorectal cancer through computational based approach

  2025cites this paper
• The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer

  2025cites this paper
• PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti‐TIGIT Therapy in Microsatellite‐Stable Colorectal Cancer

  2025cites this paper
• Arginine methylation modulates tumor fate and prognosis in clear cell renal cell carcinoma

  2025cites this paper
• PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C‐Myc Feedback Loop

  2025cites this paper
• Congenital heart disease missense mutations in the TBX5 DNA-binding domain alter thermal stability and DNA-binding affinity

  2025cites this paper
• Emerging roles of protein arginine methyltransferase in multiple myeloma

  2025cites this paper
• Discovery and Mechanism of 16-19F, a Novel Synthetic Lethal Inhibitor of the PRMT5•MTA Complex in MTAP-Deleted Cancer Cells.

  2025cites this paper
• PRMT1 inhibition enhances the cardioprotective effect of adipose-derived mesenchymal stem cells against myocardial infarction through RUNX1

  2025cites this paper
• Identification of a Selective Cell‐Active Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) for the Treatment of Prostate Cancer by Structure‐Based Virtual Screening

  2025cites this paper
• Development of a Selective and Potent PRMT4 PROTAC Degrader with Efficacy against Multiple Myeloma in Vitro and in Vivo.

  2025cites this paper
• Inhibiting UPF1 methylation enhances tumor immunotherapy sensitivity by reducing nonsense-mediated mRNA decay.

  2025cites this paper
• Exploiting Synthetic Lethality of PRMT5 for Precision Treatment of MTAP-Deficient Glioblastoma

  2025cites this paper
• A novel 3-alkenylindol-2-one derivative selectively inhibits the growth of acute myeloid leukemia via modulation of the MYC-PRMT pathway.

  2025cites this paper
• Heat shock factor 1 promotes proliferation and chemoresistance in diffuse large B-cell lymphoma by enhancing the cell cycle and DNA repair

  2025cites this paper
• Loss of 4.1B Drives PRMT3-Mediated Regulation of GBM Brain Tumour Stem Cell Growth

  2025cites this paper
• Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells

  2025cites this paper
• Epigenetic mechanisms in HCC immune landscape: Therapeutic implications.

  2025cites this paper
• Endothelial PRMT7 prevents dysfunction, promotes revascularization and enhances cardiac recovery post-myocardial infarction

  2025cites this paper
• PRMT2 promotes tumorigenic phenotypes through the Wnt signaling pathway and drives immune suppression in Colorectal cancer.

  2025cites this paper
• In Silico discovery of novel androgen receptor inhibitors for prostate cancer therapy using virtual screening, molecular docking, and molecular dynamics simulations

  2025cites this paper
• Protein arginine methyltransferase 1 stimulates basal cell proliferation and migration to maintain corneal epithelial homeostasis

  2025cites this paper
• Hypoxia‐Induced PRMT1 Lactylation Drives Vimentin Arginine Asymmetric Dimethylation in Tumor Metastasis

  2025cites this paper
• PRMT5 encourages cell migration and metastasis of tongue squamous cell carcinoma through methylating ΔNp63α.

  2025cites this paper
• Discovery of novel indazole derivatives as type Ⅰ PRMTs inhibitors for the treatment of triple-negative breast cancer.

  2025cites this paper
• The Role of PRMT5 in Embryonic Developmental Arrest: Insights from IVF-ET Discarded Human Embryos

  2025cites this paper
• PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer

  2025influential citation
• Prmt1-mediated methylation regulates Ncoa4 stability to transactivate Adamts genes and promote bone extracellular matrix degradation in chronic hematogenous osteomyelitis

  2025cites this paper
• Inhibition of Clostridioides difficile-Specific DNA Adenine Methyltransferase CamA by Analogs of S‑Adenosyl‑l‑methionine

  2025cites this paper
• The Identification of a Sub-Micromolar Peptide-Based Protein Arginine Methyltransferase 1 (PRMT1) Inhibitor from a Plate-Based Screening Assay

  2025cites this paper
• Arginine methylation in cancer: mechanisms and therapeutic implications

  2025influential citation
• Dismantling the epigenetic alliance: Emerging strategies to disrupt the PRMT5:MEP50 complex for cancer therapy.

  2025cites this paper